Company intelligence / Profile preview

RPL France

Vandœuvre-lès-Nancy, Grand Est, France

Ownership: Private
Development stage: Other

Overview

Recherche et Pharmacologie de Lorraine (RPL) was a French contract research organization (CRO) specializing in clinical pharmacology and drug development services. Founded in 1989 and based in Vandœuvre-lès-Nancy, the company provided a comprehensive range of Phase I to IV clinical trial services to the pharmaceutical and biotechnology industries. RPL was particularly recognized for its expertise in early-phase clinical trials, operating a dedicated clinical pharmacology unit. In 2004, the company was acquired by SGS, a global leader in inspection, verification, testing, and certification, to strengthen its Life Science Services division in Europe. Following the acquisition, RPL's operations were integrated into the SGS global network of clinical research facilities.

Industry: Contract Research Organization

Beyond the preview

Go deeper on RPL France.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RPL France.

Explore the full profile